论文部分内容阅读
资料来源:FDA发布时间:2013.03.12FDA于2013年3月批准了Lymphoseek(99锝标记的tilmanocept)注射剂可用于淋巴结定位,它是一种放射性的诊断显像剂,帮助医师定位正在接受肿瘤引流淋巴结手术切除治疗的乳腺癌或黑色素瘤患者的淋巴结。淋巴结过滤在身体组织内流动的淋巴液。这种液体可以含有癌细胞,并种植到身体其它部位。通过检查出并手术切除肿瘤引流淋巴结,可以帮助医师确定是否癌细胞已经扩散。
Source: FDA Release Date: 2013.03.12 FDA approved Lymphoseek (a 99 technetium-labeled tilmanocept) injection for lymphatic mapping in March 2013. It is a radioactive diagnostic imaging agent that helps physicians locate patients undergoing tumor draining lymph nodes Surgical resection of lymph nodes in patients with breast cancer or melanoma. Lymph nodes filter the lymph fluid flowing in body tissues. This fluid can contain cancer cells and grow elsewhere on the body. By examining and surgically resecting the tumor draining lymph nodes, the physician can be assisted in determining if the cancer cells have spread.